With the end of year quickly approaching, the Aesthetics team at Guidepoint Qsight reviewed several years of trending data from Qsight Aesthetics Point-of-Sale and Qsight Aesthetics Tracker to unpack how behavior changes at MedSpas and Aesthetics practices in and around the holiday season.

The peripheral thrombectomy market in the United States has been witnessing significant growth and innovation in recent years. With new devices constantly entering the market, Qsight’s healthcare facilities purchasing data has been monitoring the impact of these new products.

Qsight has been monitoring the Axonics F15 SNM System since its launch in March 2022. Our healthcare facilities dataset shows that Axonics experienced a rapid increase in sales after the launch of this system, as this system offers a recharge-free option that now directly competes with Medtronic’s Interstim X.